Apoptosis-Modulating Drugs for Improved Cancer Therapy von Ocker, M., Höpfner, M.

Volltext

Jet printing of convex and concave polymer micro-lenses von Blattmann, M, Ocker, M, Zappe, H, Seifert, A

Volltext

Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy von Kim, S-M, Kim, H, Yun, M R, Kang, H N, Pyo, K-H, Park, H J, Lee, J M, Choi, H M, Ellinghaus, P, Ocker, M, Paik, S, Kim, H R, Cho, B C

Volltext

Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer von Ocker, M, Neureiter, D, Lueders, M, Zopf, S, Ganslmayer, M, Hahn, E G, Herold, C, Schuppan, D

Volltext

Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours von Nitzsche, B, Gloesenkamp, C, Schrader, M, Ocker, M, Preissner, R, Lein, M, Zakrzewicz, A, Hoffmann, B, Höpfner, M

Volltext

Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study von KOLODZIEJ, M, GOETZ, C, DI FAZIO, P, MONTALBANO, R, OCKER, M, STRIK, H, QUINT, K

Volltext

First-in-human phase I dose escalation study of the Bromodomain and Extra-Terminal motif (BET) inhibitor BAY 1238097 in subjects with advanced malignancies von Postel-Vinay, S, Herbschleb, K, Massard, C, Woodcock, V, Ocker, M, Wilkinson, G, Walter, A, Ewerton, F, Poelman, M, Middleton, M, Soria, J.C

Volltext

The BET bromodomain inhibitor (BET-i) BAY 1238097: Mechanism of action and pre-clinical activity in diffuse large B-cell lymphoma (DLBCL) von Bernasconi, E, Gaudio, E, Lejeune, P, Tarantelli, C, Rinaldi, A, Kwee, I, Mensah, A.A, Chung, E.Y.L, Stathis, A, Ocker, M, Zucca, E, Haendler, B, Bertoni, F

Volltext

396 The Role of Sphingosine Kinase Isoforms and Their Receptors in Glioblastoma Multiforme von Quint, K, Kolodziej, M, Strik, H, Stiel, N, Ocker, M

Volltext

3100 Phase Ib/II study of the pan-cyclin-dependent kinase (CDK) inhibitor roniciclib (BAY 1000394) in combination with chemotherapy as first-line therapy in subjects with extensive... von Cho, B.C, Dy, G.K, Govindan, R, Kim, D.W, Pennell, N.A, Zalcman, G, Besse, B, Nogai, H, Rajagopalan, P, Ocker, M, Barlesi, F

Volltext

323 ADDITIVE ANTI-TUMOR RESPONSE TO THE RABBIT VX2 HEPATOMA BY COMBINED RADIO FREQUENCY ABLATION AND TOLL LIKE RECEPTOR 9 STIMULATION von Wissniowski, T.T, Ocker, M, Strobel, D, Neureiter, D, Schuppan, D

Volltext

Heat dissipation after nonanatomical lung resection using a laser is mainly due to emission to the environment: an experimental ex vivo study von Kirschbaum, A., Ocker, M., Bartsch, D. K., Quint, K.

Volltext

1235-P: Effects of Medicaid Expansion on Uninsured Rates: Diabetes Belt vs. Non-Belt Counties von LOBO, JENNIFER M., KIM, SOYOUN, OCKER, GABRIELLE M., KANG, HYOJUNG, MCMURRY, TIMOTHY L., SOHN, MIN-WOONG

Volltext

1029 ATP-binding Cassette Transporter Inhibition by Tyrosine Kinase Inhibitor Nilotinib von Quint, K, Di Fazio, P, Montalbano, R, Lingelbach, S, Ocker, M

Volltext

ATP-binding cassette transporter inhibition by tyrosine kinase inhibitor Nilotinib von Quint, K, Rückert, F, Ocker, M

Volltext

267 PANOBINOSTAT TREATMENT NEGATIVELY MODULATES ONCOGENIC MIRNAS IN LIVER CANCER CELLS von Henrici, A, Montalbano, R, Quint, K, Ocker, M, Di Fazio, P

Volltext

463 (PB451): Exploring the potential of TCX-101, an antibody targeting a tumorassociated carbohydrate antigen, as a bispecific T cell engager for the treatment of solid tumors von Winkler, W., Moreira, G. Marcal Schmidt Garcia, Muraca, F., Gomes, F. Gueths, Sondermann, P., Ocker, M.

Volltext

447 (PB435): Implementation and Validation of an Innovative Platform to Discover Monoclonal Antibodies Targeting Tumor-Associated Carbohydrate Antigens (TACAs) for Cancer Immunothe... von Moreira, G., Winkler, W., Muraca, F., Gomes, F., Sondermann, P., Ocker, M.

Volltext

Embryonic Transcription Factors CDX2 and Oct4 Are Overexpressed in Neuroendocrine Tumors of the Ileum: A Pilot Study von Heverhagen, A.E., Geis, C., Fendrich, V., Ramaswamy, A., Montalbano, R., Di Fazio, P., Bartsch, D.K., Ocker, M., Quint, K.

Volltext

582 EXPRESSION OF HDAC ISOENZYMES AS A PROGNOSTIC MARKER IN HEPATOCELLULAR CARCINOMA von Quint, K, Agaimy, A, Steindorf, C, Hellerbrand, C, Ocker, M

Volltext